Construction of Nef-positive doxycycline-dependent HIV-1 variants using bicistronic expression elements

Yme U. van der Velden, Wendy Kleibeuker, Alex Harwig, Bep Klaver, Esther Siteur-Van Rijnstra, Esmay Frankin, Ben Berkhout, Atze T. Das

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

Conditionally replicating HIV-1 variants that can be switched on and off at will are attractive tools for HIV research. We previously developed a genetically modified HIV-1 variant that replicates exclusively when doxycycline (dox) is administered. The nef gene in this HIV-rtTA variant was replaced with the gene encoding the dox-dependent rtTA transcriptional activator. Because loss of Nef expression compromises virus replication in primary cells and precludes studies on Nef function, we tested different approaches to restore Nef production in HIV-rtTA. Strategies that involved translation via an EMCV or synthetic internal ribosome entry site (IRES) failed because these elements were incompatible with efficient virus replication. Fusion protein approaches with the FMDV 2A peptide and human ubiquitin were successful and resulted in genetically-stable Nef-expressing HIV-rtTA strains that replicate more efficiently in primary T-cells and human immune system (HIS) mice than Nef-deficient variants, thus confirming the positive effect of Nef on in vivo virus replication
Original languageEnglish
Pages (from-to)96-107
JournalVirology
Volume488
DOIs
Publication statusPublished - 2016

Cite this